Article

Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patients

2023-04-12

Abstract excerpt

<h4>Background: </h4> Metabolic syndromes (MetS) are clinical syndromes involving multiple pathological states with distinct gender differences clinical patterns. As a serious psychiatric disorder, the prevalence of MetS is significantly higher in this subgroup of the population with schizophrenia (Sch). The aim of this paper is to report gender differences in the prevalence, associated factors and severity-relate...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 9ce83fc6-1eed-58ce-bad1-ec506571f0ca
DOI: 10.21203/rs.3.rs-2781627/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Gender differences in prevalence and associated factors of metabolic syndrome in first-treatment and drug-naïve schizophrenia patientsDOI 10.21203/rs.3.rs-2781627/v1Read

Prevalence and factors associated of metabolic syndrome in first- treatment drug-naïve schizophrenia patients: a large-scale cross- sectional studySemantic proximity Read

A systematic review of genetic variants associated with metabolic syndrome in patients with schizophrenia.Semantic proximity Read

Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptomsSemantic proximity Read

Schizophrenia patients with a metabolically abnormal obese phenotype have milder negative symptoms.Semantic proximity Read

The heterogeneity of metabolic syndrome presentation and challenges this causes in its pharmacological management: a narrative review focusing on principal risk modifiers.Semantic proximity Read

Genetic predisposition and antipsychotic treatment effect on metabolic syndrome in schizophrenia: a ten-year follow-up study using the Estonian BiobankSemantic proximity Read

The relationship between brain-derived neurotrophic factor and metabolic syndrome in patients with chronic schizophrenia: A systematic review.Semantic proximity Read

Metabolic syndrome in patients taking clozapine: prevalence and influence of catechol-O-methyltransferase genotype.Semantic proximity Read

Genome-wide associations with metabolic syndrome among UK Biobank participants reporting use of second-generation antipsychotics.Semantic proximity Read

Genome Wide Association Study (GWAS) Identifies Novel Genetic Loci for Second-Generation Antipsychotics (SGA)-Induced Metabolic Syndrome (MetS).Semantic proximity Read

Prevalence and associated factors of metabolic syndrome among Chinese adults and elders with multi-level generalized estimation equation modelsSemantic proximity Read

From Molecules to the Clinic: Linking Schizophrenia and Metabolic Syndrome through Sphingolipids MetabolismSemantic proximity Read